Amongst the items on the agenda is the consideration and approval of the full year Audited Financial Statements of the Company for the year ended 31 December 2021 and issues around dividend.
- Also read;
- Here are some of Russia’s sanctions survival strategy
- List of Dividends announced in 2022, qualification and payment dates
The press release by the company reiterated that the closed period to prevent Insiders who have regular access to MAYBAKER’s financial information from trading in the shares of the Company has been in the force from Saturday, 1st January 2022.
The closed period will be lifted 24 hours after the accounts are submitted to the Exchange following the board meeting.
About the Company
May & Baker Nigeria Plc. was incorporated as a private limited liability company in Nigeria on September 4, 1944 and commenced business on the same date. It was listed on the Nigerian stock exchange in 1994.
The company is involved in the manufacture, sale and distribution of human pharmaceuticals, human vaccines and consumer products. Registered business address is 3/5 Sapara street, Industrial Estate, Ikeja, Lagos, Nigeria.
May & Baker have 1,725,234,886 outstanding shares and a market capitalization of N7.76 billion.
Nnamdi Maduakor is a Writer, Investor and Entrepreneur